Sign in
4

Changes in Ownership

ARS Pharmaceuticals, Inc. Filed Acc 0001398595-26-000002

Options or other derivatives

  • Chief Legal Officer acquired 240,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Fitzpatrick Alexander A Chief Legal Officer 2026-01-02 Grant or award · Stock option (right to buy) +240,000 240,000 D
Loading xslF345X05/form4-01052026_090101.xml…